Find uplifting stories about heroes, innovations, and solutions
11 results for "mrna vaccine"
Moderna has agreed to pay Roivant up to $2.25 billion to settle a patent lawsuit over its groundbreaking Covid-19 vaccine technology. The settlement could become one of the largest in patent history while keeping life-saving vaccine innovation moving forward.
A 1989 Nobel Prize-winning discovery revealed RNA could perform chemistry, not just carry instructions. That breakthrough now enables mRNA vaccines, CRISPR gene editing, and treatments for diseases once thought incurable.
The FDA reversed its decision and will now review Moderna's groundbreaking mRNA flu vaccine, marking a potential leap forward in flu prevention. This could bring the same technology that revolutionized COVID vaccines to seasonal flu shots.
A personalized mRNA vaccine helped 11 women with aggressive breast cancer stay cancer-free for up to six years. The groundbreaking treatment trained their immune systems to recognize and fight cancer cells using their own tumor's genetic code.
After rejecting Moderna's flu vaccine application just a week ago, the FDA reversed course and will now review the promising mRNA shot. The new technology could revolutionize how we protect ourselves from seasonal flu.
A major new study of 434 children brings reassuring news for pregnant mothers: getting the COVID-19 mRNA vaccine during pregnancy shows no link to autism or developmental delays. The research tracked children up to 30 months old and found identical outcomes whether mothers received the vaccine or not.
Britain just approved its first domestically manufactured mRNA vaccine, marking a major milestone in pandemic preparedness. The new Moderna facility in Oxfordshire can produce up to 250 million doses per year during health emergencies.
Mexico signed a groundbreaking agreement with Moderna to manufacture mRNA vaccines domestically, including potential vaccines for dengue and cancer. The five-year partnership will transfer cutting-edge vaccine technology to Mexican facilities and support local scientific research.
Scientists have cracked a major puzzle in malaria prevention using mRNA vaccine technology to overcome a natural barrier that weakened previous vaccines. The breakthrough could transform protection against a disease that still causes hundreds of millions of infections each year.
A personalized mRNA cancer vaccine combined with immunotherapy reduced the risk of deadly skin cancer returning by nearly 50% over five years. The breakthrough treatment is now entering final-stage trials while researchers test similar vaccines for lung, bladder, and kidney cancers.
A personalized mRNA vaccine from Moderna and Merck has shown remarkable five-year results against aggressive skin cancer. The therapy nearly halves the risk of melanoma returning after surgery.